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Aim: The expression differences of SCN8A (which encodes type VIII alpha subunit of voltage gated sodium channel) and NDUFC2 (which 
encodes C2 subunit of Complex I enzyme in oxidative phosphorylation) genes were evaluated in paired colorectal cancer (CRC) tissues 
which was relied on our partial transcriptome analysis data in cancer cell lines. Materials and Methods: A total of 62 paired tissues 
of CRC patients (34 male, 28 female) were included in the study. The mRNA levels of SCN8A and NDUFC2 genes were determined 
by using real-time PCR (qRT-PCR and semiquantitative PCR). Results: SCN8A gene expression level was significantly lower in tu-
mor tissues (p = 0.0128) and in the patients with the age below 45 years (p = 0.0049). There were also meaningful relationships between 
the gender, grade of CRC, tumor location, histopathological classification, and SCN8A expression. There was no NDUFC2 differen-
tial expression. However, the tumors taken from right colon had significantly lower NDUFC2 expression. Conclusion: Although 
the voltage gated sodium channels (VGSCs) and Complex I (CI) were associated to a number of diseases including different types 
of cancers, the different subunits of CI and individual members of VGSCs seem to be cancer type-specific in varying proportions.
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Colorectal cancer (CRC) is one of the most com-
mon types of cancer worldwide [1]. In the United 
States, CRC is the third in the leading causes of death 
due to cancer among men and women [1]. Thirty per-
cent of CRC cases have familial basis while 67% are 
sporadic, and the rest 3% of the cases have inherited 
CRC syndromes. The complex etiology of sporadic 
CRC involves a combined effect of genetic and envi-
ronmental risk factors [2].
Various genes are affected in terms of expression 
during the multistep malignant transformation into 
CRC [3]. Among those genes, plasma membrane ion 
channel encoding genes are of special importance 
since they are involved in intracellular signaling events 
and they activate specific cellular responses. However, 
ion channels research is considered relatively novel 
in cancer studies [4] and the transcriptional regula-
tion is not well characterized for the sodium channel 
genes [5]. The evidences suggesting the correlation 
of ion channels with cancer are accumulating and 
the voltage gated sodium channels (VGSCs) were 
associated to invasion and metastasis behaviors 
of several types of cancers [4, 6–8]. Among those 
channels, sodium channel, voltage gated, type VIII, 
alpha subunit (Nav1.6) is encoded by SCN8A gene. 
SCN8A has specific roles in neurons and skeletal and 
cardiac muscles [5]. The gene is located on 12q13 and 
the transcript variants of this gene encode two distinct 
proteins which are 1980 and 1939 amino acids (aa) 
in length (http://www.ncbi.nlm.nih.gov/gene/6334). 
An approximate 40-fold overexpression of SCN8A 
gene was detected in cervical cancer samples [9]. 
Another significant increase in SCN8A mRNA expres-
sion in prostate cell lines was detected, as well [10].
Complex I (CI), NADH: ubiquinone oxidoreduc-
tase is of critical importance for cell physiology and 
is the first multiprotein complex involved in the forma-
tion of the proton-motive force in mitochondria. Its 
main function is to transport the electrons by oxida-
tion of NADH followed by reduction of ubiquinone [11, 
12]. The genes encoding various CI subunits were 
associated with diseases including severe neonatal 
lactic acidosis, Leigh syndrome, neonatal cardio-
myopathy with lactic acidosis, leukodystrophy with 
macrocephaly, and hepatopathy with renal tubulopa-
thy [12, 13] and malignancies including breast, colon 
and thyroid cancers [14–17]. Human CI is composed 
of 45 subunits making it the largest and most com-
plicated enzyme in the oxidative phosphorylation 
system. Thirty-nine of the subunits of mammalian 
CI are encoded by the nuclear genome and the rest 
is encoded by the mitochondrial genome [13]. Among 
those, NDUFC2 gene is located on 11q14.1 and 
the transcript variants of this gene encode three dis-
tinct proteins which are 119, 88, and 96 aa. in length 
(http://www.ncbi.nlm.nih.gov/gene/4718). The down-
regulation of NDUFC2 gene in papillary thyroid carci-
noma was previously reported [16]. The chromosomal 
cytoband region 11q14.1 spanning NDUFC2 gene 
was shown as amplified in estrogen receptor nega-
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tive breast cancer and this region was associated with 
worse prognosis of this disease, as well [15]. Addition-
ally, NDUFC2 gene was suggested as being one of the 
candidate genes involved in microsatellite instability 
of colon adenomas [14].
SCN8A and NDUFC2 genes are members of dif-
ferent and almost unrelated pathways which also are 
of importance in terms of CRC development and 
progression. However, this pilot study was relied 
on our partial transcriptome analysis results in which 
we determined altered expression of SCN8A and 
NDUFC2 genes in various cancer cell lines. Current 
study was planned to confirm our previous findings 
and it is aimed to evaluate the gene expression diffe-
rences of SCN8A and NDUFC2 genes in CRC tissues.
MATERIALS AND METHODS
Subjects and sample collection.  A total 
of 62 (34 male, mean age — 58.8±11.2; 28 female, 
mean age — 53.8 ± 12.5) CRC patients who under-
went surgery were included in the study. Paired tumor 
and tumor-surrounding normal tissues of the patients 
were used. Samples were placed into liquid nitrogen 
immediate after the surgery and kept in −80 °C until 
RNA isolation.
Fifty-four of the samples were adenocarcinoma 
while 8 were mucinous adenocarcinoma, according 
to the histopathological classification. Six of the tumors 
were located in cecum, 12 in right colon, 2 in transverse 
colon, 11 in left colon, 10 in sigmoid colon, and 21 were 
located in rectum.
This study was approved by the local ethical com-
mittee in concordance with the declaration of Hel-
sinki (University of Gaziantep, Clinical research ethical 
committee, protocol # 219/11.06.2013). Written 
consent was taken from all of the patients.
RNA isolation and gene expression analysis. 
RNA isolation was made by using RNA isolation kit 
(QIAGEN, Germany) according to the instructions 
of the manufacturer. RNA concentrations were deter-
mined by using spectrophotometer (NanoDrop, ND-
1000, USA). cDNA synthesis was performed by using 
AMV first strand cDNA synthesis kit (New England 
Biolabs, UK) according to the instructions of the manu-
facturer. Expression primers spanning SCN8A and 
NDUFC2 mRNAs were designed by using Primer-BLAST 
(http://www.ncbi.nlm.nih.gov/tools/primerblast/). 
Primer sequences were presented in Table 1. GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase) 
gene was used as the housekeeping gene used for 
normalization of the expression results of the genes 
of interest.
Table 1. The characteristics of the primer pairs used for expression analysis
Gene Primer sequence Product length (bp.)
Annealing tem-
perature (°C)
NDUFC2 F: TTGCTTCTAATTGCACCAAGCTC 150 58R: AGAAGGTGGTTTCGAAGGAGG
SCN8A F: CCAAACTAAAGGTGCACGCC 148 58R: TGGAAGTCACCATTCCGGTG
GAPDH F: GGTCCACCACCCTGTTGCTGT 456 65R: AGACCACAGTCGATGCCATCAC
Gene expression levels were determined by using 
real-time PCR (qRT-PCR) on LightCycler® 480 instru-
ment. PCR conditions were as follows: 2 min at 50 °C, 
10 min at 95 °C, 40 cycles of 15 s at 95 °C, 30 s at 60 °C, 
and 30 s at 72 °C. Semi-quantitative PCR analysis was 
conducted prior to qRT-PCR analysis in order to con-
firm the findings (Fig. 1). Thermal conditions were 
as follows; 5 min at 95 °C, 35 cycles of 30 s at 95 °C, 
30 s at appropriate annealing temperature presented 
in Table 1, 30 s at 72 °C and 5 min at 72 °C.
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Fig. 1. Semi-quantitative PCR results of NDUFC2 and SCN8A 
genes. Top: Two percent agarose gel image of randomly selected 
8 samples’ results were shown. GAPDH gene was utilized for 
normalization of the expression values by using. NormalTarget Gene/
Reference Gene-TumorTarget Gene/Reference Gene formula. Bottom: The graphs 
show the average expression levels of the samples. The intensity 
of the bands were quantitated and densitometric analysis was 
made by using ImageJ software (v1.46r). A general decrease 
in the expression values of NDUFC2 and SCN8A genes in tumor 
tissues compared to normal tissues were prominent.
NDUFC2; Mean, N:1,24, T:1,16; Std. Deviation, N:0,62, T:0,44; 
Std. Error, N:0,079, T:0,056
SCN8A; Mean, N:1,29, T:1,14; Std. Deviation, N:0,56, T:0,54; 
Std. Error, N:0,072, T:0,069
Statistical analysis. After normalization by using 
GAPDH expression, Cp (Crossing point) values were 
used for the statistical analysis. Calculation was made 
by using 2-ΔCp formula as previously described [18]. 
The expression levels of SCN8A and NDUFC2 in tumor 
and paired normal tissues were compared. The rela-
tionships between age, gender, grade of the tumor, 
tumor location, histopathological classification, and 
gene expression levels were also evaluated. Wilcoxon 
test was used for the statistical analyses by using 
GraphPad Prism (v.5) software. All statistical tests were 
two-tailed and p < 0.05 was considered as significant.
RESULTS
SCN8A gene expression level was significantly 
lower in tumor tissues compared to paired normal 
tissues (p = 0.0128) (Table 2, Fig. 2). The decrease 
in expression was much more significant in the patients 
with the age below 45 years (p = 0.0049). Of the other 
patient parameters evaluated, there were also me-
aningful relationships between the gender (female; 
p = 0.012), grade of CRC (grade II; p = 0.02), tumor 
location (cecum; p = 0.031 and right colon; p = 0.021), 
histopathological classification (adenocarcinoma; 
p = 0.017) and SCN8A expression CRC (Table 2).
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There was no NDUFC2 gene expression diffe rence 
between the tumors and paired normal tissues in overall 
(Fig. 3). However, the tumors taken from right colon had 
significantly lower NDUFC2 expression when compared 
to paired normal tissues (p = 0.042) (Table 2).
Table 2. The patients characteristics, tumor grades, tumor locations, his-
topathological classifications and the results of the statistical analyses 
Parameter
Sample 
count, 
n (%)
p values
SCN8A NDUFC2
Age range < 45 (38.8 ± 4.19) 11 (17.7) 0.0049 0.57
45–60 (53.25 ± 4.45) 28 (45.2) 0.22 0.97
> 60 (69.04 ± 5.4) 23 (37.1) 0.3 0.84
Sex Female 28 (45.2) 0.012 0.79
Male 34 (54.8) 0.25 0.85
Grade Grade II 17 (27.4) 0.02 0.84
Grade III 11 (17.7) 0.63 0.96
Grade IV 34 (54.8) 0.15 0.87
Tumor loca-
tion
Cecum 6 (9.7) 0.031 0.56
Colon 35 (56.4) 0.12 0.36
Right colon 12 (19.4) 0.021 0.042
Transverse colon 2 (3.2) NS NS
Left colon 11 (17.7) 0.14 0.7
Sigmoid colon 10 (16.1) 0.27 0.62
Rectum 21 (33.9) 0.25 0.14
Histopatho-
logical classi-
fication
Adenocarcinoma 54 (87.1) 0.017 0.71
Mucinous adenocarcinoma 8 (12.9) 0.54 0.25
Total 62 (100) 0.0128 0.97
NS — not significant.
0
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*
Fig. 2. Calculated 2-ΔCp values of tumor and paired normal tissues 
for SCN8A gene. N — normal tissue; T — tumor tissue; *denotes 
statistical significance
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Fig. 3. Calculated 2-ΔCp values of tumor and paired normal tis-
sues for NDUFC2 gene. N — normal tissue; T — tumor tissue
DISCUSSION
As of the other types of cancer, the complexity 
of CRC is a major obstacle in understanding of the 
genetics of the disease [2]. Therefore, molecular 
classification of CRC still remains a challenge that re-
searchers have to overcome in the coming years [19]. 
The implementation of effective CRC biomarkers may 
be realized by better understanding of cancer. In our 
study, we have evaluated the gene expression diffe-
rences of SCN8A and NDUFC2 genes both of which are 
involved in different and important cellular processes, 
in CRC tissues and surrounding healthy colonic 
mucosa, by using qRT-PCR method. The rationale 
of the study was based on our preliminary results.
Differential expression and/or genetically altera-
tions of the members of the VGSCs might be involved 
in the progression of the malignant growth [4]. In our 
study, the expression of SCN8A gene which encodes 
Nav1.6 was significantly lower in CRC samples. 
Interestin gly, this decrease was much more significant 
in the patients with the age below 45 years. Accumu-
lating data suggest that VGSCs, especially Nav1.5, 
Nav1.6, and Nav1.7, were associated with various 
types of cancers in terms of oncogenic advantage and 
invasion capacity [7, 10, 20, 21]. However, the expres-
sion profiles of the individual members of VGSCs are 
highly variable. In a study aiming to investigate func-
tional expression of alpha subunits of VGSCs in hu-
man ovarian cancer; only Nav1.1, Nav1.3, Nav1.4, and 
Nav1.5 mRNAs were overexpressed in ovarian cancers 
among the 12 members of VGSCs [7]. In the same 
study, only Nav1.2, Nav1.4, Nav1.5, and Nav1.7 mRNAs 
were overexpressed in metastatic ovarian cancers. 
Taken together, the individual members of VGSCs 
were differentially expressed specific to cancer type 
and its malignancy potential. Previous studies reported 
overexpression of SCN8A gene in cervical cancer and 
prostate cancers [9, 10]. However, in our study there 
was downregulation of SCN8A mRNA in CRC tissues. 
This decrease, appears to be CRC-specific, may be due 
to the aforementioned cancer-type dependent expres-
sion of VGSCs. The other alpha subunits of VGSCs could 
also be associated with CRC. Additionally, the alter-
natively-spliced members of VGSCs may also involve 
in CRC progression [8]. The overexpression of VGSCs 
might be an important factor in triggering metastasis 
and motility due to the altered electrophysiological 
status of the cell [4]. The altered expressions of VG-
SCs, either as a whole or as particular members, might 
be key in developing potential diagnostic or therapeutic 
targets [10]. Because this was a pilot study, we did not 
determine the protein expression levels of SCN8A and 
we did not determine the expression levels of VGSCs 
other than SCN8A, either. Further studies are needed.
Except for the samples excised from right colon, 
there was no significant expressional change for 
NDUFC2 gene in this study. This was contrary to our 
expectation. This might be due to the heterogenicity 
of cancer cells. NDUFC2 gene encodes one of the 
45 subunits of CI [13]. CI is a huge complex and 
it is placed in a complicated physically and func-
tionally interconnected cellular network [12]. In our 
previous study [16], we reported downregulation 
of NDUFC2 in papillary thyroid carcinoma. Additionally, 
CI was associated to a number of diseases including 
different types of cancers [14,15]. However, the type 
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of CI subunit and whether they are encoded from 
nuclear or mitochondrial genome seems to be dise-
ase-specific. Therefore, the evaluation of CI subunits 
as a whole and the protein expressions of these indivi-
dual subunits are warranted. NDUFC2 protein has three 
isoforms (http://www.ncbi.nlm.nih.gov/gene/4718). 
The primer sets used in this study for gene expression 
analysis of NDUFC2 gene were spanning the shared 
sequence of all three isoforms. Hence, the expres-
sion levels we determined were in overall; rather than 
isoform-specific. The potential differential expres-
sions of NDUFC2 splice variants should be tested. 
As the SCN8A gene, NDUFC2 gene expression was 
decreased for the samples taken out from the right co-
lon. This data should also be verified in larger cohorts.
CRC is one of the most common cancers worldwide 
and diagnosis of CRC could be conducted in a non-
invasive manner by the usage of molecular markers. 
The discovery of new markers and the combinations 
of them with the others is thought to increase the di-
agnostic efficiency. This pilot study represents the 
expression profiling of SCN8A and NDUFC2 genes each 
of which encode one of the subunits of two important 
(and unrelated with each other) complexes in terms 
of CRC development and progression. Further studies 
aiming to evaluate the relationship between CRC and 
other CI subunits and other members of VGSCs in terms 
of mRNA and protein expressions are warranted.
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